STOCK TITAN

Olink to Report First Quarter 2021 Financial Results on May 20, 2021

(Neutral)
(Neutral)
Tags
conferences earnings

Rhea-AI Summary

Olink Holding AB (Nasdaq: OLK) will release its first-quarter 2021 financial results before market open on May 20, 2021. The management team will host a conference call at 8:00 a.m. ET to discuss these results. Investors can listen in by dialing the designated numbers based on their location. Olink specializes in proteomics and collaborates with biopharmaceutical companies and academic institutions to advance human biology understanding. Established in 2016, Olink is headquartered in Uppsala, Sweden, and operates across Europe, North America, and Asia.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – OLK

-5.06%
-5.06% Session move

In the trading session that priced this news, OLK declined 5.06%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

UPPSALA, Sweden, April 29, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK), a global leader in proteomics, today announced that it will release financial results for the first quarter of 2021 before the market open on Thursday, May 20, 2021. Company management will host a conference call to discuss financial results at 8:00 a.m. ET.

Investors interested in listening to the conference call may do so by dialing (833) 562-0120 for domestic callers or (661) 567-1096 for international callers, followed by Conference ID: 5167217. A live and archived webcast of the event will be available on the “Investors” section of the Olink website at investors.olink.com.

About Olink
Olink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The Company was founded in 2016 and is well established across Europe, North America and Asia. Olink is headquartered in Uppsala, Sweden.

Contacts
Stina Thorman
stina.thorman@olink.com
+46707187354


FAQ